← Back to Search

Depression Prevention Programs for Adolescents (P2P Trial)

N/A
Waitlist Available
Led By Tracy RG Gladstone, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
A current diagnosis of Major Depression
Any past self-harm attempt with moderate or greater lethality
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study, 30 months
Awards & highlights

Summary

This trial will compare the effectiveness of two different depression prevention programs to see which is better at preventing depressive illness in adolescents. The trial will also assess the participants', parents', and providers' experiences with each intervention approach.

Who is the study for?
This trial is for teens aged 13-19 with a history of depression but not currently depressed, showing elevated depressive symptoms without severe drug/alcohol abuse or high-risk psychiatric conditions. They shouldn't be on recent medication for mood disorders or engaged in cognitive therapy.
What is being tested?
The PATH 2 Purpose study compares two programs: CATCH-IT and TEAMS, aimed at preventing depression among adolescents. Participants are randomly assigned to one of the interventions across various locations, assessing their effectiveness and experiences during COVID-19.
What are the potential side effects?
Since CATCH-IT and TEAMS are psychological interventions rather than medications, they may cause emotional discomfort or stress due to discussing personal issues but typically do not have physical side effects like drugs.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with Major Depression.
Select...
I have attempted self-harm with moderate or greater seriousness in the past.
Select...
I am experiencing thoughts of harming myself.
Select...
I am not interested in participating in the trial anymore.
Select...
I am currently receiving treatment for a mood disorder.
Select...
I am not willing to follow the study's rules.
Select...
I am not willing to join the TEAMS groups.
Select...
My parent or guardian has a cognitive or intellectual disability.
Select...
I am outside the specified age range for the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study, 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, 30 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Intervention
Anxiety Symptoms
Blood Pressure
+24 more
Secondary study objectives
Implementation themes
Moderation of Covid-19 factors on comparative effectiveness outcomes

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CATCH-ITExperimental Treatment1 Intervention
Competent Adulthood Transition with Cognitive-behavioral \& Interpersonal Training (CATCH-IT) is an internet-based depression prevention program that targets decreasing modifiable risk factors while enhancing protective factors in at-risk adolescents, and that includes a parent program. It has been shown to be safe, feasible, and efficacious.
Group II: TEAMSActive Control1 Intervention
Teens Achieving Mastery over Stress (TEAMS) is an 8-session group depression prevention program teaching teens how to deal with stress and negative moods, and ways to manage low mood based on cognitive-behavioral therapy (CBT) principles and strategies. Efficacy has been demonstrated by several trials over time.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CATCH-IT
2020
N/A
~1170

Find a Location

Who is running the clinical trial?

University of Illinois College of Medicine RockfordOTHER
1 Previous Clinical Trials
44 Total Patients Enrolled
Wellesley CollegeOTHER
5 Previous Clinical Trials
2,486 Total Patients Enrolled
4 Trials studying Depression
2,386 Patients Enrolled for Depression
Advocate Health CareOTHER
54 Previous Clinical Trials
1,509,392 Total Patients Enrolled
2 Trials studying Depression
1,542 Patients Enrolled for Depression

Media Library

CATCH-IT Clinical Trial Eligibility Overview. Trial Name: NCT04290754 — N/A
Depression Research Study Groups: TEAMS, CATCH-IT
Depression Clinical Trial 2023: CATCH-IT Highlights & Side Effects. Trial Name: NCT04290754 — N/A
CATCH-IT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04290754 — N/A
~117 spots leftby Sep 2025